Maxim Group Maintains Vivani Medical(VANI.US) With Buy Rating, Maintains Target Price $8
Buy Rating Justified: Vivani Medical's Promising NPM-115 Implant and Strategic Market Positioning
Maxim Group Reaffirms Their Buy Rating on Vivani Medical (VANI)
Vivani Medical Analyst Ratings
ThinkEquity Initiates Coverage On Vivani Medical With Buy Rating, Announces Price Target of $7